Our weekly podcast from Politics Home discussing all the ups and downs in Westminster. Please subscribe and share - and keep up with all the latest news on PoliticsHome.com. Got a question for the team? news@politicshome.com.
…
continue reading
Innhold levert av Pharma and BioTech News and BioTech News. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Pharma and BioTech News and BioTech News eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!
Gå frakoblet med Player FM -appen!
Pharma and Biotech Daily: Roche's Breast Cancer Drug Approval, Teva's Settlement, and Biotech Industry Updates
MP3•Episoder hjem
Manage episode 445073343 series 3478766
Innhold levert av Pharma and BioTech News and BioTech News. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Pharma and BioTech News and BioTech News eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche has received regulatory approval for its breast cancer drug, inavolisib, for advanced breast cancer, projecting $2.3 billion in peak sales. This drug is seen as a potential competitor to Novartis' pi3k inhibitor piqray.Teva has agreed to pay $450 million in a settlement with the Department of Justice over kickback and price-fixing allegations. Upstream Bio raised $255 million in an IPO for inflammatory disease work, while Camp4 Therapeutics received $75 million for RNA-targeting drug development.Senator Elizabeth Warren has expressed concerns about Novo Nordisk's $16.5 billion acquisition of Catalent, warning that it could reduce competition in the market. Genscript is hosting the Biotech Global Forum 2025 on January 15, 2025, focusing on gene and cell therapy innovations.Stealth received support for ultra-rare disease drugs, Sanofi and Denali abandoned a multiple sclerosis study, and Lilly is facing challenges in its obesity clinical program. Layoffs have been announced at Medtronic, CareFusion, and Turnstone Biologics. For job opportunities in the biotech industry, Recursion, NKarta Inc., Foresight Diagnostics, and Insmed Incorporated are hiring for various positions.
…
continue reading
59 episoder
MP3•Episoder hjem
Manage episode 445073343 series 3478766
Innhold levert av Pharma and BioTech News and BioTech News. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Pharma and BioTech News and BioTech News eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche has received regulatory approval for its breast cancer drug, inavolisib, for advanced breast cancer, projecting $2.3 billion in peak sales. This drug is seen as a potential competitor to Novartis' pi3k inhibitor piqray.Teva has agreed to pay $450 million in a settlement with the Department of Justice over kickback and price-fixing allegations. Upstream Bio raised $255 million in an IPO for inflammatory disease work, while Camp4 Therapeutics received $75 million for RNA-targeting drug development.Senator Elizabeth Warren has expressed concerns about Novo Nordisk's $16.5 billion acquisition of Catalent, warning that it could reduce competition in the market. Genscript is hosting the Biotech Global Forum 2025 on January 15, 2025, focusing on gene and cell therapy innovations.Stealth received support for ultra-rare disease drugs, Sanofi and Denali abandoned a multiple sclerosis study, and Lilly is facing challenges in its obesity clinical program. Layoffs have been announced at Medtronic, CareFusion, and Turnstone Biologics. For job opportunities in the biotech industry, Recursion, NKarta Inc., Foresight Diagnostics, and Insmed Incorporated are hiring for various positions.
…
continue reading
59 episoder
Tüm bölümler
×Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.